Open-label study to assess reduction of background asthma medication while sustaining asthma control and clinical remission with tezepelumab in patients 12-80yrs with severe asthma.

Trial Identifier:	D5180C00047
Sponsor:	AstraZeneca
Collaborator:	Fortrea
Start Date:	September 2024
Primary Completion Date:	June 2027
Study Completion Date:	June 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.